Big Pharma bids to build bridges in Ireland
Irish industry’s chief looks for partnership as he admits trust is lacking
Pfizer CEO Ian Read to stand down
Ex-chief of innovative health unit Bourla to assume control as Read becomes executive chairman
Pfizer M&A on hold pending clarity on US tax reform
Sales slip for third quarter in a row as leading drug group misses analyst projections
Washington turmoil is proving a bitter pill for Pfizer
Pharma giant facing into expiry of key patents and investors are becoming itchy
Pfizer US drug prices jump as Trump prepares for clampdown
Pharma giant increase US price of nearly 100 medicines by average of 20 per cent this year
Drugmaker Pfizer abandons plan to split into two
Company’s shares down 1.3% in premarket trading after it says it will not separate
Pfizer to seek permission for Grange Castle plant expansion
Several hundred jobs likely to be created at former Wyeth facility in west Dublin
Stocktake: Investors nonchalant about Brexit threat?
Impact on share prices of uncertainty over UK’s EU future difficult to calculate
Pfizer chief lashes out at US crackdown on Allergan deal
Ian Read says rules to stop inversions will create ‘permanent advantage’ for rivals
Collapse of Pfizer-Allergan deal will be mourned by few
Except for the firms involved, few in the US or Ireland benefit from inversion deals
Pfizer-Allergan deal is a ‘travesty’ - Icahn
Activist investor Carl Icahn argues that deal will open the floodgates for other companies to leave the US
Fixing America’s ‘inversion’ problem rests at home
Democrats call for US tax reform after Pfizer, Allergan agree $160bn Irish-based merger
Pfizer takes over Allergan in $160bn deal
Deal makes Ireland home to the largest pharmaceutical company in the world
State may gain up to €620m in Pfizer’s Allergan deal
Pfizer $160bn purchase of Allergan will see firm move HQ to Dublin
Pfizer to buy Allergan in $160bn deal to create No. 1 drugmaker
Offer, the biggest ever in the healthcare sector, values Allergan shares at $363.63 each
Pfizer $150bn takeover of Allergan looks set to be sealed
Merger will create world’s largest drugmaker and renew focus on Ireland’s role in tax inversion
Pfizer inversion bid sparks US agonising
Cantillon: Pfizer/Allergan deal the biggest of any sort yet attempted in pharma/medtech sector
Allergan warns US against any move on tax inversion deals
CEO warns that any attempt to block a takeover by Pfizer would be a “short-sighted intervention”
Cantillon: Allergan fits the bill if the Pfizer price is right
No one questioning wisdom of approach or ability of companies to do a deal
Pfizer in merger talks with Botox-maker Allergan
Takeover could offer tax advantages given that Allergan is based in Dublin
Pfizer beats third quarter sales and profit forecasts
Sales fell 2 per cent, hurt by generic competition and expiration of a deal with Amgen
Pfizer said to be in takeover talks with Actavis
Acquisition could allow the US drugmaker to move overseas and reduce taxes
AstraZeneca rejects Pfizer’s ‘final’ £70bn takeover proposal
British firm says US company had failed to make a compelling case
AstraZeneca rejects Pfizer’s ‘final’ £70bn takeover offer
Plans to create world’s largest drug company in doubt as Pfizer offer fails to meet approval
Planet Business
This week: Straight-talk coins, ‘monetary morphine’ and stock ticker symbols with a difference
Merging Pfizer and AstraZeneca will create ‘science powerhouse’
MPs told new entity would deliver much better outcomes for range of diseases
Pfizer chief faces hostile grilling on takeover bid
Westminster not happy with Ian Reid’s pledges on takeover of AstraZeneca
Pfizer urges AstraZeneca to talk as British MPs slam offer
Chief executive Ian Read faces hostile questions over his proposed $106 billion play for UK firm
Pfizer defends business case behind plan to acquire AstraZeneca
US firm says commitments to Britain are legally binding
Pressure on Pfizer to keep UK onside
Group is not known for being backwards when it comes to rationalisation
Pfizer under fire in Europe, US as it weighs next Astra move
Pharma company’s record of cutting jobs after mergers has provoked a political backlash
Pfizer hints at hostile takeover bid for AstraZeneca
US pharma giant reports first quarter sales of $730 million, below analyst estimates
Quarterly results due out from Pfizer and Perrigo
US pharma giant is currently in a $100 million battle for Britain’s AstraZeneca
Pfizer warns UK government not to block £60bn AstraZeneca bid
Chief executive Ian Read arrives in London for talks with government ministers
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices